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ABSTRACT
RAD51 is a key factor in homologous recombination
(HR) and plays an essential role in cellular prolifer-
ation by repairing DNA damage during replication.
The assembly of RAD51 at DNA damage is strictly
controlled by RAD51 mediators, including BRCA1
and BRCA2. We found that human RAD51 directly
binds GEMIN2/SIP1, a protein involved in
spliceosome biogenesis. Biochemical analyses
indicated that GEMIN2 enhances the RAD51–DNA
complex formation by inhibiting RAD51 dissociation
from DNA, and thereby stimulates RAD51-mediated
homologous pairing. GEMIN2 also enhanced the
RAD51-mediated strand exchange, when RPA was
pre-bound to ssDNA before the addition of RAD51.
To analyze the function of GEMIN2, we depleted
GEMIN2 in the chicken DT40 line and in human
cells. The loss of GEMIN2 reduced HR efficiency
and resulted in a significant decrease in the
number of RAD51 subnuclear foci, as observed in
cells deficient in BRCA1 and BRCA2. These obser-
vations and our biochemical analyses reveal that
GEMIN2 regulates HR as a novel RAD51 mediator.
INTRODUCTION
Double-strand breaks (DSBs) arise spontaneously and are
also induced by environmental factors such as ionizing
radiation (IR) and topoisomerase I and II inhibitors
(reviewed in 1,2). There are two main DSB repair
pathways: homologous recombination (HR) and
non-homologous end-joining (NHEJ) (reviewed in 3,4).
HR is preferred when DSBs occur as a consequence of
replication blocks. DSBs in sister chromatids are
repaired using the intact sister chromatid as a template.
Null HR-deﬁcient vertebrate cells, such as RAD51
 / 
cells, display extensive chromosomal breakage in mitotic
cells and fail to go through even a single cell cycle (5).
Thus, HR plays an essential role in the maintenance of
chromosomal DNA during replication.
The current model for HR-mediated DSB repair is that
DSBs are ﬁrst recognized by the ATM kinase, which phos-
phorylates histone H2AX in their vicinity (6). The Mre11
complex, CtIP and the UBC13-mediated ubiquitylation of
chromatin proteins are involved in the processing of DSBs
to generate 30 single-stranded DNA (ssDNA) tails (7, 8).
These ssDNA tails are associated with the ssDNA binding
protein, RPA, which is subsequently replaced by RAD51.
This replacement is promoted by a number of RAD51
mediators, including the tumor-suppressor gene, i.e.
Breast Cancer Susceptibility Gene 1 (BRCA1), BRCA2,
and ﬁve RAD51 paralogs (RAD51B/C/D, and XRCC2/3)
(reviewed in 9, 10). The resulting RAD51–DNA ﬁlament
undergoes homologous pairing, strand invasion into intact
homologous double-stranded DNA (dsDNA) to form a
D-loop structure, and strand exchange. The RAD51-
mediated D-loop formation is stimulated by RAD54 and
RAD51AP1 (11–15). DNA synthesis from the invading
strand, followed by dissociation from the homologous
duplex DNA and re-annealing of the newly synthesized
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repair (reviewed in 16).
The assembly of RAD51 at 30 ssDNA tails is strictly
regulated by the RAD51 mediators (reviewed in 17).
Thus, cells deﬁcient in the mediators, such as RAD51
paralogs and BRCA2, consistently show a signiﬁcant
decrease in the number of RAD51 subnuclear foci, but
not in the number of foci containing the RPA ssDNA
binding protein at DNA damage. Despite the essential
role of vertebrate RAD51 in cellular proliferation, cells
deﬁcient in the RAD51 mediators exhibit a less prominent
phenotype, indicating that the mediators do participate in
HR, presumably by controlling the activity of RAD51
(5,18–21). Recent studies have reported the successful re-
constitution of in vitro HR using ﬁssion yeast RAD51 and
RAD51 mediators (22,23). However, the molecular mech-
anisms underlying the action of mammalian RAD51 me-
diators are poorly understood. A mammalian RAD51
mediator, the RAD51B–RAD51C complex, has been
puriﬁed (24). This RAD51 paralog complex may not
function alone as the RAD51 mediator, because the
genetic data suggest that the ﬁve RAD51 paralogs form
a functional unit wherein each one is essential in
promoting the assembly of RAD51 at DNA damage
(18). Although the function of BRCA2 has been extensive-
ly studied on a cellular level, its function has not been
characterized in in vitro HR reactions, since it has not
been possible to purify the complete BRCA2 protein.
Instead, biochemical studies of truncated BRCA2
proteins suggest that BRCA2 facilitates the assembly of
RAD51, presumably by directly interacting with both the
damaged DNA and RAD51 (25–31). It is still unclear how
BRCA1 facilitates the accumulation of RAD51 at 30
ssDNA tails.
We then studied RAD51-interacting proteins using
yeast two-hybrid analysis, and found human GEMIN2
as a candidate protein. GEMIN2 is a 32-kDa protein
with no homology to any other protein, and is known to
form a stable RNA-protein complex with several other
components, including the GEMIN and SMN proteins
(32). The SMN protein is the product of the survival
motor neuron (SMN) gene. Mutation of the SMN gene
is responsible for spinal muscular atrophy (SMA), which
is a neurodegenerative disease accompanied by the loss of
motor neurons (33,34). The homozygous gene-disruption
of either GEMIN2 or SMN is lethal to early mouse em-
bryogenesis, while GEMIN2 knockdown using the small
interference RNA (siRNA) treatment leads to a drastic
decrease in the assembly activity of spliceosomal small
nuclear ribonucleoprotein (snRNP) (35). The genetic and
biochemical studies cited here indicate that GEMIN2 and
the SMN proteins constitute a core complex that is essen-
tial for the formation of a functional SMN complex.
Additionally, this complex plays an essential cellular role
in the assembly of spliceosomal snRNPs, a process that is
partially disrupted in SMA.
In the present study, we found that human GEMIN2
physically interacts with RAD51. Immunoprecipitation
experiments indicated that GEMIN2 and RAD51 form
a complex. To evaluate the DNA repair function of
GEMIN2, we performed in vitro HR assays and also
analyzed the phenotype of GEMIN2-depleted cells.
Puriﬁed GEMIN2 protein enhances the complex forma-
tion between RAD51 and DNA, and stimulates
RAD51-mediated homologous pairing and strand
exchange. In agreement with these biochemical results,
the depletion of GEMIN2 in the chicken B cell line
DT40 (36) as well as in human cells signiﬁcantly reduced
the recruitment of RAD51 to DNA lesions. In summary,
our observations reveal that GEMIN2 has another unex-
pected function: regulating the RAD51 recombinase and
thereby promoting HR-dependent repair.
MATERIALS AND METHODS
Yeast two-hybrid screening of GEMIN2 cDNA
The two-hybrid analysis of the N-terminal
RAD51-fragment (1–114 amino acid residues) interaction
was carried out using a Matchmaker two-hybrid cDNA
library from human testis (Clontech, Mountain View, CA,
USA). The human GEMIN2 gene was cloned from a
human testis cDNA pool (purchased from Clontech) by
polymerase chain reaction (PCR). The DNA fragments
containing sequences derived from RAD51 and
GEMIN2 were ligated into the pACT2 and pAS2-1
vectors (Clontech), respectively. The pAS2-1 and pACT2
plasmids contain the GAL4 DNA-binding domain and
the GAL4 activation domain, respectively, just upstream
of their cloning sites. The plasmids for the positive control
experiment (pGBKT7-53 and pGADT7-T) and for the
negative control experiment (pGBKT7-Lam and
pGADT7-T) were supplied by the manufacturer
(Clontech). The plasmids containing the RAD51 and
GEMIN2 sequences were introduced into the yeast
strain AH109. The two-hybrid interaction between
RAD51 and GEMIN2 was then tested according to the
manufacturer’s protocol (Clontech Matchmaker GAL4
protocol). The interaction between RAD51 and
GEMIN2 induced the expression of the HIS3, ADE2
and LacZ reporter genes, which allow the yeast strain to
grow on a synthetic dextrose minimal medium plate
without histidine and adenine, and to produce a blue
color in the presence of X-Gal.
Protein puriﬁcation
The human GEMIN2 gene was ligated into the NdeI site
of the pET15b plasmid (Novagen, Darmstadt, Germany).
The His6-tagged GEMIN2 protein was overexpressed in
the Escherichia coli strain BL21(DE3), which also carried
an expression vector for the minor tRNAs
[Codon(+)RIL, Novagen]. The E. coli cells containing
the GEMIN2-expressing plasmid were cultured at 30 C.
At the logarithmic phase of growth (A600=0.6), the
GEMIN2 production was induced with 1mM isopropyl-
1-thio-b-D-galactopyranoside (ﬁnal concentration), and
the cells were further cultured for 12h at 18 C. The cells
were disrupted by sonication in buﬀer A [50mM Tris-HCl
(pH 7.5), 500mM NaCl, 2mM 2-mercaptoethanol and
10% glycerol]. The cell debris was clariﬁed by centrifuga-
tion, and the supernatant was mixed with 4ml of ProBond
resin (Invitrogen, Carlsbad, CA, USA). The sample was
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buﬀer A. The resin was packed in a column and washed
with 200ml of buﬀer A, containing 30mM imidazole. The
resin was further washed with 40ml of 50mM Tris-HCl
buﬀer (pH 7.5), containing 2mM 2-mercaptoethanol,
30mM imidazole and 10% glycerol, and the protein was
eluted by a linear gradient of imidazole from 30mM to
500mM. The ProBond fractions containing the His6-
tagged GEMIN2 protein were collected and fractionated
on a Superdex 75pg column (GE Healthcare Biosciences,
Uppsala, Sweden), which was previously equilibrated with
buﬀer B [20mM Tris-HCl (pH 8.0), 1M NaCl, 0.25mM
EDTA, 2mM 2-mercaptoethanol and 10% glycerol]. The
His6-tagged GEMIN2 protein eluted from the Superdex
75pg column was treated with 2.5U/mg of thrombin
protease (GE Healthcare Biosciences) during dialysis
against buﬀer C [20mM Tris-HCl (pH 8.0), 0.25mM
EDTA, 2mM 2-mercaptoethanol and 10% glycerol].
After removal of the His6 tag, GEMIN2 was further
puriﬁed by MonoQ column chromatography (GE
Healthcare Biosciences). Puriﬁed GEMIN2 was stored in
20mM HEPES-NaOH buﬀer (pH 7.5), containing
200mM NaCl, 0.1mM EDTA, 2mM 2-mercaptoethanol
and 10% glycerol at  80 C. To prepare Cy5-labeled
GEMIN2, puriﬁed GEMIN2 (1.3mg) and Cy5 maleimide
mono-reactive dye (0.2mg, GE Healthcare Biosciences)
were incubated at 4 C for 1h. Free Cy5 dye was
removed by NAP10 gel ﬁltration column chromatography
(GE Healthcare Biosciences). Human RAD51 was
puriﬁed as described earlier (37).
Assay for RAD51–GEMIN2 binding
RAD51 (40mg) was covalently conjugated to Aﬃ-Gel 10
beads (75ml, Bio-Rad Laboratories, Hercules, CA, USA),
according to the manufacturer’s instructions, and the Aﬃ-
Gel 10-protein matrices were adjusted to 50% slurries.
GEMIN2 (8mg) was incubated with RAD51-conjugated
Aﬃ-Gel 10 beads (2.5mg of RAD51) in 100mlo f2 0 m M
potassium phosphate buﬀer (pH 7.5), containing 0.05%
Triton X-100. After incubation at room temperature for
2.5h, the RAD51 beads were extensively washed with
20mM potassium phosphate buﬀer (pH 7.5), containing
150mM NaCl, 0.1mM EDTA, 2mM 2-mercaptoethanol
and 10% glycerol. Proteins bound to the RAD51 beads
were fractionated by a 15% SDS–PAGE. Bands were
visualized by Coomassie Brilliant Blue staining.
Immunoprecipitation
We used 3 10
7 HeLa cells for the RAD51 binding
Flag-tagged chicken GEMIN2 immunoprecipitation ex-
periments. The Flag-chicken GEMIN2 expression vector
was transfected into HeLa cells by Lipofectamine 2000
(Invitrogen). At 48h after the transfection, the cells were
washed three times with cold PBS buﬀer and harvested.
After centrifugation, collected cells were mixed with 400ml
of lysis buﬀer [300mM NaCl, 50mM Tris-HCl (pH. 7.5),
1mM NaF, 0.5% NP-40 and 10% Glycerol], supple-
mented with a protease inhibitor cocktail (Complete
Mini, Roche, Mannheim, Germany) and kept on ice for
5min. After addition of BSA (1% ﬁnal concentration), the
resulting cell lysates were each sonicated ﬁve times for
30sec and centrifuged at 4 C. The supernatant was col-
lected as a whole-cell extract. One microgram of antibody
RAD51 (Ab-1, Calbiochem, Darmstadt, Germany) and
20ml of DYNA-protein G beads (DYNAL, Carlsbad,
CA, USA) were mixed and incubated overnight in PBS
containing 1% BSA at 4 C to conjugate the antibody
and beads. The mixture was then washed with the lysis
buﬀer. A 360ml aliquot of the whole-cell extract was
mixed for 120min with the pre-treated beads for
immunoprecipitation at 4 C. The resulting precipitates
were washed ﬁve times with the lysis buﬀer (containing
0.1% BSA). The washed precipitates were mixed with
40ml of the standard SDS ﬁnal sample buﬀer, boiled for
5min and subjected to SDS gel-electrophoresis.
DNA substrates for in vitro reactions
Single-stranded fX174 viral (+) strand DNA and
double-stranded fX174 replicative form I DNA were
purchased from New England Biolabs (Ipswich, MA,
USA). The linear dsDNA was prepared from the fX174
replicative form I DNA by PstI digestion. The dsDNA
fragments were prepared from pGsat4 DNA (38) by
Alw44I digestion. High-pressure liquid chromatography-
puriﬁed oligodeoxyribonucleotides were purchased from
Nihon Gene Research Laboratory. The DNA sequences
used in this study are: 49-mer ssDNA: 50-CCA ATG CGC
TTG GTA AAC ATG CTC AGG ATT GCG ACG CTA
GCA AGT GAT C-30, and 49-mer dsDNA: 50-GTC CCA
GGC CAT TAC AGA TCA ATC CTG AGC ATG TTT
ACC AAG CGC ATT G-30,5 0-CAA TGC GCT TGG
TAA ACA TGC TCA GGA TTG ATC TGT AAT
GGC CTG GGA C-30 and 50-CCA ATG CGC TTG
GTA AAC ATG CTC AGG ATT GCG ACG CTA
GCA AGT GAT C-30.
Measurement for binding of RAD51 and GEMIN2 to
ssDNA and dsDNA
The reaction mixtures (10ml) contained 28mM HEPES
buﬀer (pH 7.5), 300mM NaCl, 0.04mM EDTA, 0.8mM
2-mercaptoethanol, 1mM ATP, 1mM DTT, 100mg/ml
BSA, 1mM MgCl2 and 4% glycerol. RAD51 was
incubated in the presence or absence of GEMIN2 or
Cy5-labeled GEMIN2 at 37 C for 5min, and then either
the fX174 ssDNA (20mM) or the linearized fX174
dsDNA was added. After incubation for 15min, the
protein–DNA complexes were analyzed by 0.8% agarose
gel electrophoresis in 1 TAE buﬀer (40mM Tris-acetate
and 1mM EDTA) at 3.3V/cm for 2.5h. The bands were
visualized by ethidium bromide staining. Cy5-labeled
GEMIN2 was visualized using a Typhoon9410 imaging
analyzer (GE Healthcare Biosciences).
Measurement of RAD51 assembly onto DNA
The RAD51 protein was incubated in the presence or
absence of the GEMIN2 protein at 37 C for 10min, and
then the ssDNA 49-mer (10mM) or the dsDNA 49-mer
(6mM) was added. Reactions were performed in 10mlo f
20mM potassium phosphate buﬀer (pH 7.5), containing
70mM NaCl, 1mM ATP, 1mM DTT, 100mg/ml BSA,
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the RAD51–ssDNA and Rad51–dsDNA ﬁlaments were
analyzed by 10% and 8% polyacrylamide gel electrophor-
esis in 1 TBE buﬀer (90mM Tris, 90mM boric acid and
2mM EDTA) at 7V/cm for 1.5h, respectively. The bands
were visualized by SYBR Gold (Invitrogen) staining, and
quantitated using an LAS-1000 imaging analyzer with the
Image Gauge software (Fujiﬁlm, Tokyo, Japan).
Assay for RAD51–DNA ﬁlament disassembly
RAD51 (2mM) was incubated in the presence or absence
of GEMIN2 (4mM) at 37 C for 10min in 28mM HEPES
buﬀer (pH 7.5), containing 535mM NaCl, 0.04mM
EDTA, 0.8mM 2-mercaptoethanol, 1mM ATP, 1mM
DTT, 100mg/ml BSA, 1mM MgCl2 and 4% glycerol.
The linearized fX174 dsDNA was then added, and the
volume of the reaction mixture was adjusted to 10ml.
After an incubation at 37 C for 10min, these mixtures
were incubated with various concentrations of the
Alw44I-digested pGsat4 dsDNA fragments (0–50mM) at
37 C for 2h. The products were fractionated by 0.8%
agarose gel electrophoresis in TAE buﬀer at 3.3V/cm
for 2.5h, and visualized by staining with ethidium
bromide and quantitated using an LAS-1000 imaging
analyzer with the Image Gauge software (Fujiﬁlm).
Measurement of RAD51 disassembly by the BRC4
polypeptide
The BRC4 polypeptide used in this assay was purchased
from Toray Research Center, Inc. (Tokyo, Japan). The
amino acid sequence of the BRC4 polypeptide is as
follows: LLGFHTASGKKVKIAKESLDKVKNLFDE.
RAD51 (2mM) was incubated in the presence or absence
of GEMIN2 (4mM) at 37 C for 10min in 20mM potas-
sium phosphate buﬀer (pH 7.5), containing 30mM NaCl,
0.04mM EDTA, 0.8mM 2-mercaptoethanol, 1mM ATP,
1mM DTT, 100mg/ml BSA, 1mM MgCl2 and 4%
glycerol. The linearized fX174 dsDNA was then added,
followed by an incubation with the BRC4 polypeptide
(0, 0.5, 1 and 2mM) at 37 C for 1h. The volume of the
reaction mixture was 10ml. The protein–DNA complexes
were analyzed by 0.8% agarose gel electrophoresis at
3.3V/cm for 2.5h in 1 TAE buﬀer, and the bands
were visualized by ethidium bromide staining and then
quantitated using an LAS-1000 imaging analyzer with
the Image Gauge software (Fujiﬁlm).
The D-loop formation assay
RAD51 and GEMIN2 were incubated at 37 C for 5min in
8ml of reaction buﬀer, containing 24mM HEPES-NaOH
(pH 7.5), 35mM NaCl, 0.02mM EDTA, 0.4mM
2-mercaptoethanol, 2% glycerol, 1mM MgCl2,1 m M
DTT, 2mM ATP, 2mM CaCl2 and 0.1mg/ml BSA.
After this incubation, 1mlo fa
32P-labeled 50-mer oligo-
nucleotide (1mM, 50-GGA ATT CGG TAT TCC CAG
GCG GTC TCC CAT CCA AGT ACT AAC CGA
GCC CT-30) was added, and the samples were further
incubated at 37 C for 5min. The reactions were then
initiated by the addition of 1ml of the pB5Sarray super-
helical dsDNA (20mM), and were continued at 37 C for
30min. The pB5Sarray DNA contained 11 repeats of a sea
urchin 5S rRNA gene (207-bp fragment) within the
pBlueScript II SK(+) vector, and was prepared by a
method avoiding alkaline treatment of the cells harboring
the plasmid DNA, to prevent the dsDNA substrates from
undergoing irreversible denaturation. The reactions were
stopped by the addition of 0.1% SDS and 1.6mg/ml pro-
teinase K (Roche Applied Science, Basel, Switzerland) and
were further incubated at 37 C for 15min. After adding
6-fold loading dye, the deproteinized reaction products
were separated by 1% agarose gel electrophoresis in
1 TAE buﬀer at 4V/cm for 2h. The gels were dried,
exposed to an imaging plate and visualized using an
FLA-7000 imaging analyzer (Fujiﬁlm).
Assay for strand exchange
The fX174 circular ssDNA (20mM) was incubated with
or without 2mM RPA at 37 C for 10min in 10mlo f
20mM potassium phosphate buﬀer (pH 7.5), containing
75mM NaCl, 0.04mM EDTA, 0.8mM 2-
mercaptoethanol, 4% glycerol, 1mM MgCl2,1 m M
DTT, 1mM ATP, 100mg/ml BSA, 20mM creatine phos-
phate and 75mg/ml creatine kinase. After this incubation,
RAD51 (4mM) and the indicated amounts of GEMIN2,
which were pre-incubated at 37 C for 5min, were added to
the reaction mixture. The reactions were then initiated by
the addition of 100mM (NH4)2SO4 and 20mM fX174
linear dsDNA and were continued for 30min. The reac-
tions were stopped by the addition of 0.1% SDS and
1.97mg/ml proteinase K (Roche Applied Science), and
were further incubated at 37 C for 15min. After adding
6-fold loading dye, the deproteinized reaction products
were separated by 1% agarose gel electrophoresis in
1 TAE buﬀer at 3.3V/cm for 4h. The products were
visualized by SYBR Gold (Invitrogen) staining and
quantitated using an LAS-1000 imaging analyzer with
the Image Gauge software (Fujiﬁlm).
Surface plasmon resonance analysis
The surface plasmon resonance (SPR) signals were
measured with Biacore X100 instrument (GE
Healthcare). Flow cells were maintained at 25 C during
the measurement, and the instrument was operated at the
mid-ﬂow rate ( 30ml/min). The RAD51 or GEMIN2
protein was conjugated to the activated surface of the
CM5 sensor chips (GE Healthcare), using the standard
amine coupling conditions recommended by the manufac-
turer. The level of the conjugated RAD51 and GEMIN2
protein was 18000 and 6500 resonance units (RU). SPR
signals of the ﬂow cell containing a sensor chip without
the proteins were subtracted from those of the SPR signals
of the ﬂow cell containing the RAD51 or GEMIN2-
conjugated sensor chip. The running buﬀer was 10mM
HEPES-NaOH (pH 7.4), 150mM NaCl, 3mM EDTA
and 0.05% Tween 20. For each binding assay, 10mM
BRC4 polypeptide was injected for 2min.
Supercoiling assay
The indicated amounts of GEMIN2 or RAD51 (8mM)
were pre-incubated at 37 C for 10min in 9mlo f2 4 m M
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1mM MgCl2, 1mM DTT, 2mM CaCl2, 4% glycerol,
0.04mM EDTA, 0.8mM 2-mercaptoethanol, 70mM
NaCl, 0.1mg/ml BSA, 20mM creatine phosphate and
75mg/ml creatine kinase. The fX174 superhelical
dsDNA (20mM) was incubated with topoisomerase I
at 37 C for 1h in 15ml of 20mM HEPES-NaOH
buﬀer (pH 7.5), containing 1mM MgCl2, 1mM DTT,
100mg/ml BSA, 20mM creatine phosphate and 75mg/ml
creatine kinase. The reactions were then initiated by the
addition of 20mM fX174 relaxed dsDNA, which was
treated with wheat germ topoisomerase I. After an incu-
bation at 37 C for 30min, the reactions were stopped by
the addition of 0.1% SDS and 1.97mg/ml proteinase K
(Roche Applied Science), and were further incubated at
37 C for 15min. After adding 6-fold loading dye, the
deproteinized reaction products were separated by 1%
agarose gel electrophoresis in 1  TAE buﬀer at 1.3V/
cm at 4 C for 16h. The products were visualized by
SYBR Gold (Invitrogen) staining.
Cloning of chicken GEMIN2 cDNA
The full-length cDNA encoding for the GEMIN2 proteins
was obtained from the NCBI data bank. The Gene Bank
accession numbers are AF027150 and NM001039302 for
the human and chicken GEMIN2 genes, respectively. The
amino acid sequences of the human and chicken GEMIN2
cDNAs share 79% identity. The human GEMIN2 gene
was cloned from the human testis cDNA library
(Clontech) by PCR.
Cell culture
DT40 cells were cultured in RPMI-1640 medium supple-
mented with 10
 5M b-mercaptoethanol, penicillin
streptomycin, 10% fetal calf serum (FCS) and 1%
chicken serum (Sigma-Aldrich, St Louis, MO, USA) at
39.5 C. HeLa and U2OS cells were cultured in DMEM
supplemented with 10% FCS at 37 C.
Construction of targeting vectors
To generate targeting vectors for the chicken GEMIN2
gene, 1.5 and 3.0kb GEMIN2 genomic fragments were
obtained by PCR using DT40 genomic DNA as a
template, and were used as 50 and 30 arms, respectively.
The primers used were 50-ggg gac aac ttt gta tag aaa agt
tgG TTT TGG GCT CCG TGT GGC AGT AA-30 and
50-ggg gac tgc ttt ttt gta caa act tgC ACT TGA GCG TTG
GAG AGT ATC CT-30 for the 50 arm and 50-ggg gac agc
ttt ctt gta caa agt ggA CAA GCA CAG AAA TCA CTG
GCG GT-30 and 50-ggg gac aac ttt gta taa taa agt tgA
GAA AAC CCG TGT GTT TCC TCT GT-30 for the
30 arm. Underlined sequences denote the recognition se-
quences in the Gateway system (Invitrogen). By using the
MultiSite Gateway system with pENTR-lox-HisD,
pENTR-lox-puro and pDEST-DTA-MLS (39), a ﬂoxed
HisD
R or Puro
R gene was inserted between the 50 and 30
arms on a plasmid carrying a DT-A gene, thus yielding the
two targeting vectors: GEMIN2-HisD
R/loxP and
GEMIN2-Puro
R/loxP.
Generation of the GEMIN2 conditional mutant cells
To generate GEMIN2
 /  cells, linearized GEMIN2 target-
ing vectors (Puro
R and HisD
R) were transfected sequen-
tially by electroporation (Bio-Rad Laboratories). The
genomic DNA of the transfectants was digested with
EcoRV and the targeted clones were conﬁrmed by
Southern-blot analysis. The probe was a PCR-ampliﬁed
fragment derived from chicken DT40 genomic DNA,
using the primer set 50-CGC ATT TGT GGT GGC
TTT CAG CTT GAG ACA-30 and 50-CTT TAA GTG
GCC TCT TCT TGT CAG TGG CAG-30. The probe was
labeled using the Alkphos Direct Labelling Module (GE
Healthcare Biosciences). To generate GEMIN2
+/  cells,
wild-type (WT) DT40 cells were transfected with the
GEMIN2 targeting vector (Puro
R). Next, one of the
GEMIN2
+/  clones was transfected with the
tetracycline-controlled trans-activator (tTA) gene
(Invitrogen) and the conditional human GEMIN2 expres-
sion construct to obtain GEMIN2
+/ tetGEMIN2 cells
carrying the two transgenes at random sites on the
chromosome. Expression of human GEMIN2 and tTA
was conﬁrmed by western blotting. To generate
GEMIN2
 / tetGEMIN2 cells, GEMIN2
+/ tetGEMIN2
cells were transfected with the GEMIN2 targeting vector
(HisD
R). Expression of the chicken GEMIN2 in
GEMIN2
 / tetGEMIN2 cells was measured by employing
Reverse-transcription PCR (RT–PCR) using the
SuperScript
TM III First-Strand system (Invitrogen) and
the following primers: 50-GAG TAT ACT CAG AAA
TAG ATG CAG-30 and 50-CTA GGA GGG TTC ATC
AGC TAA-30.
siRNA transfection and colony formation assay
We depleted GEMIN2 in HeLa and U2OS cells using the
following method. The GEMIN2 siRNA used in this
study was provided by Dharmacon. The control siRNA
sequences used in this study were 50-CCC GGA CCA
CAA CGC UCU G-30. Twenty-four h prior to transfec-
tion, 2 10
5 or 3 10
6 cells were seeded in 35mm or
100mm culture dishes, and transfection was carried out
using HiperFect Transfection Reagent (Qiagen, Hilden,
Germany) and antibiotic-free media. Assays were per-
formed 48h after siRNA transfection.
Western blotting and antibodies
Cells were lysed in an SDS lysis buﬀer (25mM Tris-HCl
pH 6.5, 1% SDS, 0.24M 2-mercaptoethanol, 0.1%
Bromophenol Blue and 5% glycerol) and boiled for
5min. The aliquots were subjected to SDS–PAGE and
transferred to an Immobilon-P transfer membrane
(Millipore, Billerica, MA, USA). Antibodies speciﬁc to
human GEMIN2 [anti-gemin2 (clone 2E17), Immuquest,
Seamer, North Yorkshire, UK], RAD51 (Ab-1), mouse Ig
[horseradish peroxidase (HRP)-conjugated, GE
Healthcare Biosciences] and rabbit Ig (HRP-conjugated;
Santa Cruz Biotechnology, Santa Cruz, CA, USA) were
used for the detection.
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Immunocytochemical and laser irradiative analysis were
carried out as described by Takata et al. (18) and
Murakawa et al. (40). Before laser treatment, HeLa cells
were cultured in BrdU (10mM) containing medium for
48h and exposed to a 405nm laser from the confocal mi-
croscopy, FV-1000 (Olympus, Tokyo, Japan), to induce
DSBs. During laser treatment, cells were incubated in
phenol red-free Opti-medium (GIBCO, Carlsbad, CA,
USA) to prevent the absorption of the laser wavelength.
g-irradiation was performed using
137Cs (Gammacell 40,
Nordion, Ottawa, ON, Canada). Antibodies against
RAD51 (Ab-1), FK2 (Nippon Biotest Laboratories,
Tokyo, Japan), RPA32/RPA2 (abcam, Cambridge, MA,
USA), rabbit Ig (Alexa 488 conjugated, Molecular Probes)
and mouse Ig (Alexa 594 conjugated, Molecular probes)
were used for visualization. Fluorescence images were
obtained and processed using ﬂuorescence microscopy,
IX81 (Olympus).
Chromosome aberration analysis
Karyotype analysis was performed as described by
Sonoda et al. (5).
RESULTS
GEMIN2 directly interacts with RAD51
To identify unknown RAD51 mediators, we searched for
RAD51-interacting proteins, using a human testis cDNA
library for yeast two-hybrid screening. We used the
N-terminal RAD51 fragment (1–114 amino acid region)
as bait. The N-terminal RAD51 region forms a distinct
domain, and is accessible for interactions with other HR
factors in RAD51–DNA ﬁlaments (41,42). From
 4.8 10
5 transformants, we identiﬁed eight clones that
activated both ADE2 and HIS3 expression. The nucleo-
tide sequence analysis of these positive clones revealed
that one clone encoded GEMIN2. The interaction
between RAD51 and GEMIN2 in the yeast two-hybrid
system was re-assessed by analyzing the expression of
LacZ (blue coloring on X-Gal) and the prototrophy for
adenine and histidine (Supplementary Figure S1A). To
test whether or not RAD51 directly interacts with
GEMIN2, GEMIN2 was expressed in bacteria and
puriﬁed as a recombinant protein (Supplementary Figure
S1B). We performed a pull-down assay, using beads
associated with RAD51. GEMIN2 indeed co-pelleted
with the RAD51 beads, whereas bovine serum albumin
(BSA) did not bind to RAD51 (Supplementary Figure
S1C). We therefore conclude that GEMIN2 binds specif-
ically to RAD51.
To analyze the interaction between GEMIN2 and
RAD51 in vivo, we transiently expressed Flag-tagged
GEMIN2 in HeLa cells, exposed the cells to
Camptothecin (1), and isolated cellular extracts.
Immunoprecipitation of the extracts with anti-GEMIN2
(Flag) and RAD51 antibodies co-precipitated RAD51 and
GEMIN2, respectively (Supplemental Figure S1D),
indicating a physical interaction between GEMIN2 and
RAD51. Moreover, this interaction was signiﬁcantly
increased by having exposed the cells to Camptothecin,
which stimulates HR (1). These data support the idea
that GEMIN2 physically associates with RAD51 in vivo
as well as in vitro.
GEMIN2 enhances the formation of
RAD51–DNA complexes
To explore the function of GEMIN2 in HR, we tested
whether or not GEMIN2 can stimulate the assembly of
RAD51 onto DNA in vitro. To this end, RAD51 was
incubated with 49-mer ssDNA in the presence or
absence of GEMIN2, and the incubated products were
subjected to electrophoresis on polyacrylamide gels
(Figure 1A and B). Remarkably, pre-incubation of
RAD51 with GEMIN2, prior to the addition of ssDNA,
signiﬁcantly reduced the amount of free ssDNA in the
GEMIN2 concentration dependent manner (Figure 1A,
lanes 3–6, and Figure 1B). Similar results were obtained
using 49-mer dsDNA (Figure 1C and D) instead of
ssDNA. Hence, GEMIN2 may indeed enhance the forma-
tion of the RAD51–DNA complexes in vitro. We next
performed the RAD51–DNA binding assay with the
fX174 ssDNA (5386 bases) or dsDNA (5386bp).
Consistently, the addition of GEMIN2 to RAD51 prior
to the addition of the fX174 ssDNA or dsDNA caused
prominent retardation of their migration (Figure 1E and
F). This retardation may not be due to the association of
GEMIN2 with the RAD51–DNA complex, because it did
not carry a detectable amount of ﬂuorescently labeled
GEMIN2 (Figure 1G). We therefore conclude that
GEMIN2 enhances the formation of the RAD51–DNA
complex, without tightly associating with this complex.
It has been shown that all yeast and mammalian
RAD51 mediators, including BRCA2 and the RAD51B–
RAD51C complex, can bind to DNA in vitro (24,25). We
thus tested whether GEMIN2 binds to DNA. In contrast
to the RAD51 mediators reported previously, GEMIN2
did not aﬀect the mobility of ssDNA or dsDNA
(Figure 1E and F, lane 2). GEMIN2 did not induce topo-
logical changes in supercoiled DNA in the absence of
RAD51 (Supplementary Figure S2). Therefore,
GEMIN2 did not exhibit DNA binding under the condi-
tions used in this assay. This observation indicates that
GEMIN2 is a unique RAD51 mediator, in the sense
that it can stimulate the assembly of RAD51 on DNA
without closely associating with the DNA.
GEMIN2 inhibits the RAD51–DNA dissociation
To test whether GEMIN2 inhibited the dissociation of
RAD51 from DNA, we generated the RAD51–DNA
complex and subsequently measured the stability of this
complex in the presence of excess amounts of either com-
petitor DNA (975–1246bp) (Figure 2A and B) or the
BRCA2-derived BRC4 polypeptide (Figure 2C and D),
which is known to disassemble the RAD51–DNA
ﬁlament (43–46). In these assays, we used fX174 linear
dsDNA (5386bp) associated with RAD51 as the RAD51–
DNA complex. We evaluated the stability by measuring
the amount of free dsDNA using agarose gel
5064 Nucleic Acids Research, 2010,Vol.38, No. 15Figure 1. GEMIN2 stimulates RAD51–DNA ﬁlament formation. (A) Polyacrylamide gel electrophoresis to examine the formation of the RAD51–
DNA ﬁlament. RAD51 (4mM) and GEMIN2 were incubated with 10mM 49-mer ssDNA. DNA was visualized by SYBR Gold (Invitrogen) staining.
The GEMIN2 concentrations were 0mM (lane 2), 1mM (lane 3), 2mM (lane 4), 4mM (lane 5) and 8mM (lanes 6 and 7). Under these experimental
conditions, 90% of the input ssDNA was estimated as being in the RAD51-bound fraction in the absence of the GEMIN2 protein. (B)
Quantiﬁcation of experiments shown in panel A. The amounts of complexes formed were estimated from the residual free DNA substrates, and
unbound ssDNA fractions relative to lane 2 of panel A were plotted. Average values of three independent experiments are shown with standard
deviation values. (C) Polyacrylamide gel electrophoresis, as in panel A. RAD51 (2mM) and GEMIN2 were incubated with 6mM 49-mer dsDNA.
DNA was visualized by SYBR Gold (Invitrogen) staining. The GEMIN2 concentrations were 0mM (lane 2), 0.5mM (lane 3), 1mM (lane 4), 2mM
(lane 5) and 4mM (lanes 6 and 7). (D) Quantiﬁcation of experiments shown in panel C. The amounts of complexes formed were estimated from the
residual free DNA substrates, and unbound dsDNA fractions relative to lane 2 of panel C were plotted. Average values of three independent
experiments are shown with standard deviation values. (E) Agarose gel electrophoresis to examine the formation of the RAD51-ssDNA ﬁlament.
RAD51 was incubated in the presence or absence of the GEMIN2 protein, followed by addition of fX174 ssDNA (20mM). DNA was visualized by
ethidium bromide staining. (F) Agarose gel electrophoresis to examine the formation of the RAD51–dsDNA ﬁlament. RAD51 was incubated in the
presence or absence of the GEMIN2 protein, followed by addition of linear fX174 dsDNA (10mM). Results presented as in panel E. (G) Agarose gel
electrophoresis to assess the complex formation between the RAD51-dsDNA ﬁlament and GEMIN2. GEMIN2 was labeled with Cy5 and dsDNA
was stained with EtBr. Note that GEMIN2 facilitated the formation of the RAD51-dsDNA ﬁlament, but did not bind to the ﬁlament.
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rupted the RAD51–DNA complex, as evidenced by the
fact that substantial amounts of free fX174 linear
dsDNA were detected, as the amount of competitor
DNA was increased (Figure 2A, lanes 2–5). The disrup-
tion of the RAD51–DNA complex was signiﬁcantly sup-
pressed by the addition of GEMIN2 (Figure 2A, lanes 6–9
and Figure 2B), indicating that GEMIN2 may inhibit the
RAD51–DNA dissociation. We also analyzed the impact
of the BRC4 polypeptide on the RAD51–DNA complex
with and without GEMIN2. The BRC4 polypeptide
dissociated free RAD51 from fX174 linear dsDNA.
This inhibitory eﬀect of BRC4 on the RAD51–DNA
complex was signiﬁcantly reversed by the addition of
GEMIN2 (Figure 2C and D). SPR analysis revealed that
the BRC4 polypeptide did not bind to GEMIN2
Figure 2. GEMIN2 stabilizes the RAD51–DNA ﬁlament. (A) Complex formation of RAD51 and dsDNA was evaluated by electrophoresis of
unbound free DNA in agarose gel. Increased concentrations of competitor DNA were incubated with 2mM of RAD51 in the presence or absence of
4mM of GEMIN2, prior to the addition of fX174 dsDNA. (B) Quantiﬁcation of results from panel A. The relative amounts of RAD51-unbound
DNA are shown. Closed and open circles indicate experiments with and without GEMIN2. Average values and standard deviation were calculated
from three independent experiments. (C) Complex formation of RAD51 and dsDNA in the presence of the BRC4 polypeptide. The experiments were
done as described for panel A. (D) Quantiﬁcation of the data from panel C. (E) Surface plasmon resonance analysis. The RAD51- or
GEMIN2-conjugated sensor chips were used. Sensorgrams of RAD51-BRC4 and GEMIN2-BRC4 interactions are presented. The BRC4 polypeptide
concentration was 10mM. Time 0 of the horizontal axis indicates the initiation time of the peptide injection.
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masked the BRC4 polypeptide from the RAD51–BRC4
interaction. We therefore conclude that GEMIN2 facili-
tates the formation of the RAD51–DNA complex,
probably by inhibiting the dissociation of RAD51 from
damaged DNA sites.
GEMIN2 may enhance RAD51-mediated homologous
pairing and strand exchange in vitro
To verify that GEMIN2 plays a role in HR, we tested the
eﬀect of GEMIN2 on an in vitro HR reaction:
RAD51-mediated homologous pairing (Figure 3A). To
this end, we measured the formation of the D-loop struc-
ture between a
32P-labeled 50-mer oligonucleotide and
superhelical dsDNA. Consistent with a previous observa-
tion (47), RAD51 alone promoted homologous pairing
(Figure 3A and B, lane 2). The addition of GEMIN2 sig-
niﬁcantly increased the amount of D-loop in a
dose-dependent manner (Figure 3A and B, lanes 3–5).
Therefore, we conclude that GEMIN2 promotes
RAD51-mediated homologous pairing.
We next focused on RAD51-mediated strand exchange.
It is known that the eﬀect of RPA on in vitro strand
exchange reaction diﬀers depending on the experimental
method used (Figure 3C) (48,49). As expected, when RPA
was added after the formation of RAD51–ssDNA ﬁla-
ments, it supported to promote the RAD51-mediated
strand exchange in vitro [Figure 3C(i) and D, lanes 1–4].
On the other hand, when RPA was pre-incubated with
ssDNA before the addition of RAD51 to ssDNA
[Figure 3C(ii)], RPA did not stimulate the
RAD51-mediated strand exchange, because RPA
competed with RAD51 in ssDNA binding (Figure 3D,
lanes 5–8). We found that GEMIN2 enhanced the
RAD51-mediated strand exchange in the latter case
(Figure 3E and F). In nucleus, RAD51 is considered to
compete with RPA in the ssDNA binding at the DSB site,
and this suppressive eﬀect by RPA may be overcome by
the RAD51 mediators. Therefore, GEMIN2 may function
as a RAD51 mediator to support the RAD51–ssDNA
binding at the DSB sites in the presence of RPA. Similar
enhancing eﬀect was previously reported for yeast RAD52
(50–52), a key enzyme of HR as well as for some mam-
malian RAD51 paralog proteins (24).
Figure 3. GEMIN2 enhances the homologous-pairing and
strand-exchange activities of RAD51. (A) GEMIN2 stimulates the
RAD51-mediated homologous pairing. RAD51 and GEMIN2 were
incubated at 37 C for 5min. After this incubation, a
32P-labeled
50-mer oligonucleotide (1mM) was added, and the samples were
further incubated at 37 C for 5min. The reactions were then initiated
by the addition of the pB5Sarray superhelical dsDNA (20mM), and
were continued at 37 C for 30min. The reactions were stopped by
the addition of SDS and proteinase K, and the deproteinized reaction
products were separated by 1% agarose gel electrophoresis in 1  TAE
buﬀer. The gels were dried, exposed to an imaging plate and visualized
using an FLA-7000 imaging analyzer (Fujiﬁlm, Tokyo, Japan). The
reactions were conducted with 100nM RAD51 in the presence of
increasing amounts of GEMIN2. A schematic representation of the
homologous pairing is presented on the top of the panel. (B) Graphic
representation of the experiments shown in panel A. Amounts of
D-loops relative to that of the RAD51 alone are plotted. The
average values of three independent experiments are shown with the
SD values. (C) Schematic representations of strand-exchange reactions.
(i) The RAD51-ssDNA complexes are formed before the RPA
addition. (ii) The RPA-ssDNA complexes are formed before the
RAD51 addition. (D) Strand-exchange reactions where RPA was
added to fX174 circular ssDNA (20mM), after [lanes 1–4, panel C(i)]
or before [lanes 5–8, panel C(ii)] incubation of the ssDNA with
RAD51. Strand-exchange reactions were initiated by the addition of
fX174 linear dsDNA (20mM) and (NH4)2SO4 (100mM), and
incubated for 30min. The deproteinized products of the reaction
mixtures were separated using 1% agarose gel electrophoresis and
were visualized by SYBR Gold (Invitrogen) staining. (E) GEMIN2
enhances strand exchange. ssDNA was incubated with RPA and then
with RAD51 [panel C(ii)]. The indicated amounts of GEMIN2 were
pre-incubated with RAD51, and subsequently added to the reaction
mixture containing the ssDNA and RPA. (F) Quantiﬁcation of panel
E. The band intensities of the joint molecule (jm) products were
quantiEed as the percentage of the entire input of the ssDNA and
dsDNA molecules. Average values of three independent experiments
are shown with standard deviation values.
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To determine the function of GEMIN2 in vivo, we had to
disrupt the GEMIN2 gene. We began by designing
gene-targeting constructs to delete the two exons that
encode residues 86 to 101 of the protein (Supplementary
Figure S3A and B). However, we failed to generate
GEMIN2
 /  cells from the chicken DT40 B cell line
(36), suggesting that the inactivation of GEMIN2 is
lethal to cells. We therefore conditionally disrupted the
GEMIN2 gene using a human GEMIN2 transgene under
the control of a tetracycline-(doxycycline) repressible
promoter (tetGEMIN2 transgene). We independently
isolated two GEMIN2
 / tetGEMIN2 clones and con-
ﬁrmed that they showed the same phenotype. We then
examined the GEMIN2
 / tetGEMIN2 cells for their
levels of endogenous GEMIN2 transcripts and human
GEMIN2 protein (Supplementary Figure S3C and D) as
well as their growth properties (Supplementary Figure
S4A) in the absence and presence of doxycycline.
Without doxycycline, the GEMIN2
 / tetGEMIN2 cells
tended to grow more slowly than the WT cells, presum-
ably because human GEMIN2 is not fully functional in
chicken cells (compare Supplementary Figure S4A). Two
days after the addition of doxycycline, the level of human
GEMIN2 protein had been dramatically reduced—down
below the endogenous level of the HeLa cells
(Supplementary Figure S3D)—and the GEMIN2
 /
 tetGEMIN2 cells had begun to stop proliferating
(Supplementary Figure S4A). Over time, fractions of the
GEMIN2
 / tetGEMIN2 cells accumulated in the G1 and
G2 phases (Supplementary Figure S4B). These cells
showed a moderate increase in the number of un-repaired
DSBs, as measured by the number of spontaneous
chromosomal breaks (Supplementary Table S1) (53). By
Day 5, most of the GEMIN2
 / tetGEMIN2 cells had
stopped growing and exhibited a large population of
dead cells. These observations indicate that GEMIN2 is
essential for the cell viability.
GEMIN2 facilitates HR-mediated DSB repair in
DT40 cells
To assess the role of GEMIN2 in DSB repair, we exposed
GEMIN2
 / tetGEMIN2 cells to g-rays, and measured the
kinetics of DSB repair by counting the number of
phosphorylated histone H2AX (g-H2AX) foci
(Figure 4A) as well as by counting chromosomal breaks
in the subsequent M phase (Figure 4B). To this end, 4 days
after adding the doxycycline, we exposed an asynchronous
population of cells to 4Gy g-rays. The numbers of induced
g-H2AX foci were comparable irrespective of GEMIN2
expression (Figure 4A), indicating that GEMIN2 does
not aﬀect the kinetics of g-induced DSB formation.
However, at 6 and 12h after irradiation, larger numbers
of DSBs were left unrepaired in the GEMIN2-deﬁcient
cells than in the GEMIN2
+ cells, indicating that
GEMIN2 promotes DSB repair. We also harvested
mitotic cells after 6h and measured the number of
chromosomal breaks (Figure 4B). Note that cells
irradiated in the S to G2 phases can enter the M phase
within 6h after g-irradiation (54). GEMIN2-deﬁcient cells
exhibited a  3-fold increase in the number of induced
chromosome breaks in comparison with WT and
GEMIN2
+ GEMIN2
 / tetGEMIN2 cells. Since DSB
repair is primarily carried out by HR in DT40 cells (55),
the compromised DSB repair in the S to G2 phases raises
the possibility that GEMIN2 is required for HR-mediated
DSB repair.
To further examine HR-dependent DSB repair, we
monitored the repair kinetics by measuring the disappear-
ance of phosphorylated histone H2AX (g-H2AX) foci fol-
lowing the exposure of cells to camptothecin, a
topoisomerase I poison (Figure 4C). Camptothecin stabil-
izes the single strand cleavage-topoisomerase I complex,
which interferes with replication and thereby induces
DSBs in one of the sister chromatids [reviewed in (1)]
The resulting DSBs are repaired by HR with the intact
sister chromatid (56–59). To monitor HR-dependent
repair of camptothecin-induced DSBs, we treated
GEMIN2
 / tetGEMIN2 cells with doxycycline for 2–4
days. Similar numbers of g-H2AX foci appeared at
5min after camptothecin treatment in
GEMIN2-deﬁcient cells (Figure 4C), indicating that the
loss of GEMIN2 does not aﬀect camptothecin-induced
DSBs. Remarkably, the camptothecin-induced g-H2AX
foci disappeared with retarded kinetics in
GEMIN2-depleted cells, in comparison with GEMIN2
+
cells. Hence, GEMIN2 may facilitate HR-mediated DSB
repair.
To directly assess the role of GEMIN2 in HR, we
measured the HR-dependent repair of site-speciﬁc DSBs
generated by the I-SceI nuclease acting on an artiﬁcial
substrate inserted into the OVALBUMIN locus (60,61).
The eﬃciency of HR-dependent repair can be evaluated
by measuring the percentage of green ﬂuorescent protein
(GFP)-positive cells (Figure 5A). The percentage of GFP
+
cells was three times lower in GEMIN2-deﬁcient than in
WT and GEMIN2
+ GEMIN2
 / tetGEMIN2 cells
(Figure 5B and C), though the eﬃciency of transient trans-
fection in these cells was comparable (Figure 5D). In
summary, this observation, as well as the defective
repair of DSBs induced by g-rays and camptothecin, indi-
cates that GEMIN2 indeed facilitates HR-dependent DSB
repair.
GEMIN2 promotes assembly of RAD51 at resected
single-strand DSB tails
To determine at what stage GEMIN2 acts in HR, we
analyzed the recruitment of RAD51 to g-ray-induced
DSBs 2 and 4 days after the addition of doxycycline.
Clear RAD51 foci appeared in WT cells 3h after g-ray
irradiation (Figure 6A). In contrast, the number of
RAD51 foci decreased in GEMIN2-deﬁcient cells
(Figure 6A and B). This impaired recruitment is not due
to a decrease in the amount of RAD51, as evidenced by
the stable RAD51 protein level in the GEMIN2-depleted
cells (Supplementary Figure S3D). This suggests that
GEMIN2 increases the eﬃciency of HR by promoting
the assembly of RAD51 at DNA damage sites.
To test the reproducibility of this result in human cells,
we measured g-ray-induced RAD51 foci in U2OS cells
5068 Nucleic Acids Research, 2010,Vol.38, No. 15treated with siRNA against GEMIN2. The siRNA treat-
ment diminished the level of GEMIN2 at least 3-fold
(Figure 6C) without signiﬁcantly aﬀecting the cell cycle
(Figure 6D). The depletion of GEMIN2 by siRNA in
U2OS cells also compromised the formation of RAD51
foci following g-ray irradiation (Figure 6E). These results
conﬁrm that GEMIN2 is required for the eﬃcient recruit-
ment of RAD51 to sites of DNA damage in vertebrate
cells.
To explore the cause of the reduced RAD51 focus for-
mation, we analyzed conjugated ubiquitin foci at
g-ray-induced DSBs, and RPA accumulation at
laser-induced DSB sites in DT40 cells (7,8,62). We previ-
ously showed that UBC13 E2 ubiquitin ligase is required
for the processing of DSBs, as evidenced by the loss of
conjugated ubiquitin foci and the severely attenuated ac-
cumulation of RPA at laser-induced DSBs in UBC13
 / 
cells (8). In contrast, GEMIN2-depleted and WT cells ex-
hibited the same numbers of conjugated ubiquitin foci
(Figure 6F). Similarly, RPA was eﬃciently recruited to
laser-induced DSB sites 60min after treatment in
GEMIN2-depleted and WT cells (Figure 6G).
Collectively, these data suggest that the HR defect in
GEMIN2-deﬁcient DT40 cells is due to a failure to eﬃ-
ciently load RAD51 at resected DSBs.
DISCUSSION
GEMIN2 forms a complex with SMN and plays a critical
role in the motor neuron survival, by controlling the
assembly of spliceosomal snRNP (32). Here we have
identiﬁed an unexpected function of GEMIN2 in HR.
We initially identiﬁed GEMIN2 by using a two-hybrid
screening with RAD51 as bait (Supplementary Figure
S1A). We conﬁrmed that GEMIN2 binds RAD51
in vitro (Supplementary Figure S1C) and forms a
complex with RAD51 in vivo (Supplementary Figure
S1D). More importantly, we found that puriﬁed
GEMIN2 promotes the assembly of RAD51 on ssDNA
and dsDNA (Figure 1). Consistent with these biochemical
observations, GEMIN2 depletion reduced the amount of
RAD51 focus formation in human and chicken DT40
cells, but not the accumulation of the ssDNA binding
protein RPA at DNA damage sites (Figure 6). Puriﬁed
GEMIN2 enhanced RAD51-mediated homologous
pairing and strand exchange in vitro (Figure 3). This
in vitro observation is also in agreement with the
Figure 4. Defective repair of DSBs induced by g-rays and
camptothecin in GEMIN2-deﬁcient cells. (A) Time line of g-H2AX
foci per cell at the indicated time after treatment with 4Gy g-rays.
Results for WT cells and for GEMIN2
 / tetGEMIN2 untreated
(GEMIN2
+) and treated (GEMIN2
 ) with doxycycline for 4 days are
shown. Error bars represent standard deviation. Statistical analysis was
performed using the t test. (B) Ionizing-radiation-induced chromosome
aberrations. Mitotic cells were harvested at 6h after exposure of an
asynchronous population of cells to 4Gy g-rays. Irradiated cells were
treated with colcemid for the last 3h before harvest to enrich the
mitotic cells. Results from WT and GEMIN2
 / tetGEMIN2 cells un-
treated with doxycycline (GEMIN2
+) and treated (GEMIN2
 ) with
doxycycline for 4 days are shown. The number of chromosomal aber-
rations per 50 mitotic cells is shown on the Y-axis. Error bars represent
standard deviation. (C) Time course of the formation of g-H2AX foci
per cell at the indicated times after treatment with camptothecin (CPT,
100ng). Results for WT cells and for GEMIN2
 / tetGEMIN2 untreat-
ed (GEMIN2
+) and treated (2 days, GEMIN2
  2D; 3 days, GEMIN2
 
3D; 4 days, GEMIN2
  4D) with doxycycline are shown. CPT is
supposed to induce DSBs only in cells at the S phase, and the
number of g-H2AX foci was counted only in g-H2AX foci positive
cells. Error bars represent standard deviation.
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showed the diminished eﬃciency of HR-mediated DSB
repair (Figures 4 and 5). These results demonstrate that
GEMIN2 is a novel RAD51 mediator, as are BRCA1,
BRCA2 and the ﬁve RAD51 paralogs. Thus, GEMIN2
has dual functions: the regulation of spliceosomal
snRNP formation and the control of RAD51-dynamics
at DNA damage.
Among proteins involved in splicing, we previously
found that human PSF, which was originally identiﬁed
as a component of spliceosomes (63), directly interacts
with RAD51, and modulates the RAD51-mediated hom-
ologous pairing and strand exchange in vitro (64). PSF was
also identiﬁed as a DSB repair protein (65), and found in a
screen for proteins that interact with the RAD51 paralogs
(66). In the present study, we found that another splicing
factor, GEMIN2, also regulates the RAD51-mediated
homologous pairing and strand exchange in vitro. These
ﬁndings may imply developmental link between the
splicing and homologous-recombination reactions in
cells. Both GEMIN2 and PSF directly interacted with
RAD51, but their consequences are diﬀerent. GEMIN2
enhances the RAD51–DNA complex formation by sup-
pressing the RAD51 disassembly from the complex. On
the other hand, PSF does not inhibit the RAD51 disas-
sembly, but modulates the RAD51-mediated homologous
pairing and strand exchange, probably through its
DNA-binding activity (64,67). These diﬀerences between
GEMIN2 and PSF in the RAD51-mediated recombin-
ation reactions may reﬂect their roles in HR and
recombinational repair of DSB in cells.
The proteins involved in HR promote the action of
RAD51 in two diﬀerent manners. First, BRCA1,
BRCA2 and the ﬁve RAD51 paralogs promote the nucle-
ation of RAD51 on DNA (17). Defects in these mediators
decrease the level of RAD51 focus formation at DNA
damage sites. Second, mammalian RAD54 and
RAD51AP1 stimulate RAD51-mediated homologous
Figure 5. HR-mediated DSB repair is impaired in GEMIN2-deﬁcient cells. (A) Schematic of the HR-dependent DSB repair assay. Transient
expression of the I-SceI restriction enzyme generates a speciﬁc DSB in an artiﬁcial HR substrate, DR-GFP, inserted into the endogenous
OVALBUMIN locus. The SceGFP gene does not produce functional green ﬂuorescent protein (GFP) because of a frame-shift mutation at the
I-SceI recognition sequences. Functional GFP is produced only when the recognition sequences are eliminated by HR with the downstream internal
GFP fragment (iGFP). (B) Distribution of GEMIN2
 / tetGEMIN2 cells with or without GFP expression. The population of the cells for GFP
expression was measured at 12h after transfection of I-SceI-expression plasmid [I-Sce(+)] or control plasmid [I-Sce( )] in GEMIN2
 / tetGEMIN2
cells untreated (GEMIN2
+) and treated (GEMIN2
 ) with doxycycline for 3 days. (C) Percentage of cells expressing GFP in the indicated cell line
was calculated. Data shown are the mean of three experiments. Error bars indicate standard deviation. (D) Transient transfection eﬃciency of an
intact GFP expression plasmid in the indicated cell lines. Error bars indicate standard deviation.
5070 Nucleic Acids Research, 2010,Vol.38, No. 15Figure 6. IR-induced Rad51 subnuclear foci are decreased in the absence of GEMIN2. (A) Immunostaining of irradiated WT and GEMIN2
 / 
tetGEMIN2 cells with the Rad51 antibody. Cells were ﬁxed 3h after irradiation of 4Gy g-ray. GEMIN2
 / tetGEMIN2 cells untreated (GEMIN2
+)
and treated (GEMIN2
 , 2 or 4 days) with doxycycline are shown. (B) Quantiﬁcation of Rad51 foci in individual cells of the indicated genotype. Data
shown are the means of three experiments. Error bars indicate standard deviation. (C) U2OS cells were transfected with siRNA oligos speciﬁc to
GEMIN2 or with control siRNA. Cell extract was prepared at 48h and immunoblotted as indicated. (D) Cell-cycle distribution 48h after addition of
control (GFP) and GEMIN2-speciﬁc siRNAs. Cells were pulse-labeled with BrdU for 10min and subsequently stained with FITC-conjugated
anti-BrdU antibody (Y-axis, log scale) and propidium iodide (PI) (X-axis, linear scale). The upper gate indicates cells incorporating BrdU
(S-phase); the lower middle gate indicates G1 cells; and the lower right gate displays G2/M cells. The sub G1 fraction (lower left gates) indicates
dead cells. The numbers given in each gate indicate the percentages of gated events. (E) Rad51 focus formation in human cells depleted of GEMIN2
by siRNA. Cells were immunostained 3h after 4Gy IR exposure. The histogram shows the percentage of cells displaying less than 6 RAD51 foci, 6 to
10 foci, and more than 10 foci per cell. >100 cells were analyzed for each data point. (F) FK2-conjugated ubiquitin focus formation following IR
exposure is normal in GEMIN2-depleted DT40 cells. GEMIN2 depletion was performed by treating GEMIN2
 / tetGEMIN2 cells with doxycycline
for 4 days. Error bars indicate standard deviation. (G) The RPA ssDNA binding protein normally accumulates at DSBs 60min after exposure to a
405nm pulse laser in HeLa cells treated with siRNA against GEMIN2 or control siRNA for 48h.
Nucleic Acids Research, 2010,Vol.38, No. 15 5071pairing (11–15). Our study reveals that, unlike the ﬁrst or
second type of HR factors, GEMIN2 enhances the
RAD51–DNA complex formation probably by inhibiting
the dissociation of RAD51 from the RAD51 polymer-
DNA complex. It remains elusive how GEMIN2 regulates
RAD51–DNA dynamics. In contrast to RAD51 medi-
ators previously reported, GEMIN2 is a unique RAD51
mediator, in the sense that GEMIN2 can promote the
loading of RAD51 onto DNA without directly associating
with the damaged DNA (Figure 1H). Taking these points
together, one possible scenario for the action of GEMIN2
is that it might transiently bind to RAD51 polymerized on
DNA and might thereby prevent RAD51 from
dissociating from DNA.
In bacteria, the RAD51 homologue, RecA, is the
central enzyme, which catalyzes homologous pairing and
strand exchange. Modulators that regulate the RecA re-
combinase activity at many levels have been found (68).
Among them, DinI, which functions in the SOS response
in bacteria (69–71), reportedly enhanced stability of the
RecA ﬁlament (72). DinI binds to the RecA ﬁlament
without signiﬁcantly inhibiting DNA binding and strand
exchange by RecA (72,73). These biochemical character-
istics of bacterial DinI are reminiscent of those of
GEMIN2.
In the present study, we showed that GEMIN2
enhances the RAD51–ssDNA complex formation by in-
hibiting the RAD51 dissociation from the complex. This is
consistent with in vivo observations that GEMIN2 stimu-
lates RAD51 assembly onto the ssDNA at the DSB sites.
However, our biochemical studies also showed that
GEMIN2 enhances formation of the RAD51–dsDNA
complex, which is considered to be inactive for homolo-
gous pairing. This apparent discrepancy between in vitro
and in vivo observations may be due to the chromatin
structure in cells. In nuclei, ssDNA regions produced at
the DSB sites may be exposed from chromatin, but, in
contrast, dsDNA remains in the higher ordered chromatin
structure. The enhancement of the RAD51–dsDNA
binding may be suppressed by the chromatin structure in
cells, therefore, the stimulation of the RAD51–ssDNA
binding by GEMIN2 may dominantly function in chro-
matin context.
Vertebrate cells require more sophisticated control of
RAD51-mediated HR than do yeast species, because in
vertebrate cells, HR must (i) undergo homology search
for a considerably longer distance than in yeast, (ii)
occur only in the S to G2 phases to prevent hetero-allelic
HR and (iii) probably not interfere with NHEJ, even in
the S to G2 phases (3). To meet these requirements, a
greater number of RAD51 mediators have evolved for
vertebrate cells. In the future, we must address the dis-
tinctive and collaborative functions of the growing
number of RAD51 mediators, i.e. BRCA1, BRCA2,
RAD51B, RAD51C, RAD51D, XRCC2, XRCC3 and
GEMIN2.
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